284 related articles for article (PubMed ID: 16567003)
41. Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis--a potential mechanism in Guillain-Barre syndrome?
Jung S; Zimmer S; Lüneberg E; Frosch M; Karch H; Korn T; Toyka KV
Neurosci Lett; 2005 Jun 10-17; 381(1-2):175-8. PubMed ID: 15882812
[TBL] [Abstract][Full Text] [Related]
42. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
Yuki N
Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
[TBL] [Abstract][Full Text] [Related]
43. Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.
Nachamkin I; Liu J; Li M; Ung H; Moran AP; Prendergast MM; Sheikh K
Infect Immun; 2002 Sep; 70(9):5299-303. PubMed ID: 12183587
[TBL] [Abstract][Full Text] [Related]
44. Enhanced, sialoadhesin-dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages.
Heikema AP; Koning RI; Duarte dos Santos Rico S; Rempel H; Jacobs BC; Endtz HP; van Wamel WJ; Samsom JN
Infect Immun; 2013 Jun; 81(6):2095-103. PubMed ID: 23529622
[TBL] [Abstract][Full Text] [Related]
45. Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options.
Ebrahim Soltani Z; Rahmani F; Rezaei N
Eur Cytokine Netw; 2019 Mar; 30(1):1-14. PubMed ID: 31074417
[TBL] [Abstract][Full Text] [Related]
46. Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.
Yu RK; Usuki S; Ariga T
Infect Immun; 2006 Dec; 74(12):6517-27. PubMed ID: 16966405
[No Abstract] [Full Text] [Related]
47. Association of Anti-GT1a Antibodies with an Outbreak of Guillain-Barré Syndrome and Analysis of Ganglioside Mimicry in an Associated Campylobacter jejuni Strain.
Zhang M; Gilbert M; Yuki N; Cao F; Li J; Liu H; Li Q; Meng F; Zhang J
PLoS One; 2015; 10(7):e0131730. PubMed ID: 26197476
[TBL] [Abstract][Full Text] [Related]
48. Ganglioside mimicry and peripheral nerve disease.
Yuki N
Muscle Nerve; 2007 Jun; 35(6):691-711. PubMed ID: 17373701
[TBL] [Abstract][Full Text] [Related]
49. Novel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndrome.
Usuki S; Taguchi K; Thompson SA; Chapman PB; Yu RK
J Neurosci Res; 2010 Jun; 88(8):1651-63. PubMed ID: 20077429
[TBL] [Abstract][Full Text] [Related]
50. Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides.
Heikema AP; Bergman MP; Richards H; Crocker PR; Gilbert M; Samsom JN; van Wamel WJ; Endtz HP; van Belkum A
Infect Immun; 2010 Jul; 78(7):3237-46. PubMed ID: 20421384
[TBL] [Abstract][Full Text] [Related]
51. Cross-reactive epitopes present in campylobacter jejuni serotypes isolated from enteritis patients.
Grozdanova A; Poceva-Panovska A; Brezovska K; Trajkovska-Dokic E; Dimovski A; Apostolski S; Suturkova Lj
Prilozi; 2011; 32(1):113-25. PubMed ID: 21822182
[TBL] [Abstract][Full Text] [Related]
52. The role of endotoxin in infection: Helicobacter pylori and Campylobacter jejuni.
Moran AP
Subcell Biochem; 2010; 53():209-40. PubMed ID: 20593269
[TBL] [Abstract][Full Text] [Related]
53. Electrophoresis-assisted open-tubular liquid chromatography/mass spectrometry for the analysis of lipooligosaccharide expressed by Campylobacter jejuni.
Li J; Koga M; Brochu D; Yuki N; Chan K; Gilbert M
Electrophoresis; 2005 Sep; 26(17):3360-8. PubMed ID: 16097024
[TBL] [Abstract][Full Text] [Related]
54. Human gangliosides and bacterial lipo-oligosaccharides in the development of autoimmune neuropathies.
Yuki N
Methods Mol Biol; 2010; 600():51-65. PubMed ID: 19882120
[TBL] [Abstract][Full Text] [Related]
55. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
Yuki N; Kuwabara S
J Peripher Nerv Syst; 2007 Dec; 12(4):238-49. PubMed ID: 18042134
[TBL] [Abstract][Full Text] [Related]
56. The Guillain-Barré syndrome: a true case of molecular mimicry.
Ang CW; Jacobs BC; Laman JD
Trends Immunol; 2004 Feb; 25(2):61-6. PubMed ID: 15102364
[TBL] [Abstract][Full Text] [Related]
57. Origin, evolution, and distribution of the molecular machinery for biosynthesis of sialylated lipooligosaccharide structures in Campylobacter coli.
Culebro A; Machado MP; Carriço JA; Rossi M
Sci Rep; 2018 Feb; 8(1):3028. PubMed ID: 29445215
[TBL] [Abstract][Full Text] [Related]
58. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
Ang CW; Laman JD; Willison HJ; Wagner ER; Endtz HP; De Klerk MA; Tio-Gillen AP; Van den Braak N; Jacobs BC; Van Doorn PA
Infect Immun; 2002 Mar; 70(3):1202-8. PubMed ID: 11854201
[TBL] [Abstract][Full Text] [Related]
59. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.
Caporale CM; Papola F; Fioroni MA; Aureli A; Giovannini A; Notturno F; Adorno D; Caporale V; Uncini A
J Neuroimmunol; 2006 Aug; 177(1-2):112-8. PubMed ID: 16820217
[TBL] [Abstract][Full Text] [Related]
60. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
